Proportion of Severe Pneumonia cases approapriately treated as per the Modified IMCI guideline 15 months [clinicaltrials_resource:d0d62c27b2b3d4d84902fe93a58f562a]
Appropriate management as per modified IMCI guideline denotes Severe pneumonia cases with only chest indrawing and no other danger signs. Such cases will be managed by 1st line oral antiobiotic Amoxicillin by the 1st level health providers. The patient will be asked to come back on 3rd day for follow up when he will be reasessed. If condition improves the antibiotic will be continued for 5 days and if condition deteriorates or remain unchange second line antiobiotic Cephradine will be used. During the treatment if any danger sign appear at any stage the patient will be immediately referred.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Proportion of Severe Pneumonia cases approapriately treated as per the Modified IMCI guideline 15 months [clinicaltrials_resource:d0d62c27b2b3d4d84902fe93a58f562a]
Appropriate management as per modified IMCI guideline denotes Severe pneumonia cases with only chest indrawing and no other danger signs. Such cases will be managed by 1st line oral antiobiotic Amoxicillin by the 1st level health providers. The patient will be asked to come back on 3rd day for follow up when he will be reasessed. If condition improves the antibiotic will be continued for 5 days and if condition deteriorates or remain unchange second line antiobiotic Cephradine will be used. During the treatment if any danger sign appear at any stage the patient will be immediately referred.
Bio2RDF identifier
d0d62c27b2b3d4d84902fe93a58f562a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d0d62c27b2b3d4d84902fe93a58f562a
measure [clinicaltrials_vocabulary:measure]
Proportion of Severe Pneumonia ...... er the Modified IMCI guideline
time frame [clinicaltrials_vocabulary:time-frame]
description
Appropriate management as per ...... will be immediately referred.
identifier
clinicaltrials_resource:d0d62c27b2b3d4d84902fe93a58f562a
title
Proportion of Severe Pneumonia ...... ified IMCI guideline 15 months
@en
type
label
Proportion of Severe Pneumonia ...... 62c27b2b3d4d84902fe93a58f562a]
@en